SUMMARY -Nine-hundred-eighty-nine patients with lymphoma were studied. Fifty-three cases (5.3%) had lymphomatous craniocerebral infiltration. The principal factors of risk for this complication were: advanced stage of the lymphoma (III or IV), diffuse histiocytic, diffuse poorly differentiated lymphocytic, or mixed cellularity lymphoma histological type, bone marrow involvement, and previous systemic chemotherapy. Thirty-two per cent of the cases of meningeal lymphomatous infiltration were asymptomatic and represented autopsy findings. CT-scan was an useful test to detect brain focal parenchymatous infiltration, as opposed to meningeal infiltration. Mean survival time in patients with lymphomatous meningeal infiltration was 4.3 months, following the combined use of systemic chemotherapy, radiation therapy and intrathecal methotrexate. Two cases had primary cerebral lymphoma, although without associated immunodeficiency Twenty patients (2%) had intracranial hemorrhage, in clear relationship with platelet alterations. Fifteen patients (1.5%) had CNS infection, caused by common bacteriae or opportunistic agents. In 7 cases, the diagnosis was made at autopsy. Thirty-six autopsies were performed. In 8 cases (22%), pathologic findings such as, demyelination, microcalcificat ons, coagulative necrosis, or gliosis, suggested complications from treatment. 
therapeutic agents, and may proliferate at that level. Bone marrow involvement from lymphomatous invasion, medication toxicity, or both, can determine abnormalities in the number and function of platelets, with subsequent occurrence of hemorrhagic phenomena.
The use of chemotherapeutic agents and radiation therapy (RT) has also brought about new complications. Chemotherapy or RT can have direct toxic effects on the CNS which, in turn, can produce necrotic lesions, demyelinating micro angiopathy, or a subacute necrotizing leukoencephalopathy.
Secondly, treatment can produce immunodepression superimposed to the immunological deficiency caused by the lymphoma, thus creating conditions for the development of opportunistic infections.
In the present study, we assess the different craniocerebral lesions caused by the above mentioned mechanisms in patients with lymphoma. Table 2 .
SUBJECTS AND METHODS

Four
Table 2 -Symptoms and signs in patients with craniocerebral lymphomatous
infiltration. CSF study revealed lymphoma cells in only 14 of 18 patients in whom a subsequent autopsy showed craniocerebral lymphomatous infiltration. In 21 patients with meningeal infiltration, the CSF study showed elevated protein and the presence of lymphomatous cells in 82% of the samples. Twenty-three per cent of the cases also had low glucose in CSF.
In all cases with brain parenchymatous or skull lymphomatous infiltration, positive findings were seen on the CT scan. In 55% of the cases, there were single hyperdense images, which enhanced homogeneously after contrast administration. In the remaining cases, the images were isodense but enhanced after contrast administration. In all cases, they had varying degrees of surrounding edema and mass effect, depending on their size. They were contiguous to either the cortex or the ependymum. On these studies images either correlated with the pathological findings or disappeared after specific treatment. Nevertheless, CT scans of the head were negative in patients with lymphomatous meningitis except for one case, where there was periependimal contrast enhancement suggesting meningeal involvement.
Fourteen patients with CT scan images consistent with focal brain infiltration were treated with RT. There was subsequent disappearance of the lesions in 9 patients (64%). Twenty-one cases of lymphomatous meningeal infiltration were treated with a combination of RT at doses of 2400 to 4000 Rads, SCh, and IT Mtx. None of them showed a satisfactory response to treatment. Their survival time had a mean of 4.3 months from the onset of symptoms.
HEMORRHAGES -Twenty patients (2%) had intracranial hemorrhages. Among them, 18 had abnormalities in the platelet count or function. Two cases had an elevated platelet count, and they had intracranial hemorrhages secondary to platelet function abnormalities. The types of the intracranial hemorrhages were: diffuse suffusions (60%), petechiae (26%), or parenchimatous hematomas (26%). In 12% of cases, two or more of these findings occurred combined.
INFECTIONS -Fifteen patients (1.5%) had CNS infections. In most cases, the etiological agent was a bacteria or a virus, either in the HL or the NHL group (Table 3 ). All the infections occurred in patients on advanced stages of the lymphoma. The clinical pictures corresponded to meningoencephalitis or meningitis in 7 cases. One patient had a brain abscess caused by Staphylococcus aureus. In the remaining patients, the clinical picture consisted of confusion and focal findings without meningeal irritation signs. Diagnosis was made at autopsy in these cases.
COMPLICATIONS FROM TREATMENT -Thirty-six autopsies were performed. Lesions that can be related to treatment, i.e., circumscribed or diffuse demyelination areas, microcalcifications, coagulative necrosis or gliosis, were seen in 8 patients (Table 4) This suggests that brain bleeding in patients with lymphoma is related to bone marrow involvement from lymphomatous infiltration or from chemotherapy toxicity. As opposed to intracranial hematomas, brain suffusions and petechiae are more frequently an autopsy finding, as previously suggested 9. Patients with lymphoma are well-known for their predisposition to infections. Opportunistic agents, the association of different infectious agents com promising the same host, or the appearance of several infectious foci, are a frequent occurrence in these patients 26 >5 4 . According to Hooper et al. 26 , 2.7% of patients with HL and 0.6% of those with NHL develop some kind of CNS infectious compli cation in the course of their disease. In our series, the incidence of such compli cation was 1.9 and 1.2% in each group, respectively. Because of their poor sympto matology, early diagnosis of the CNS infection is frequently difficult in these patients 54. In 7 cases (46%), diagnosis of ONS infection was made at autopsy, in agreement with other series 7 .
Common bacteriae, as well as opportunistic agents, are capable of causing CNS infections in immunocompromised patients at varying frequencies 6,7,26. In our series, we observed a predominance of bacterial and viral agents, even though we also found Trypanosoma cruzi, a parasite, causing one case of meningoencephalitis. This last entity was initially described in 1911 62 , and was subsequently seen in patients with immunodeficiency from different etiologies 30. 45 .
Previous work has reported neurotoxicity from IT Mtx, RT, and less frequently, from SCh The current longer life expectancy in patients with lymphoma determined an increase in the appearance of the different types of craniocerebral involvement, most of which carry a severe prognosis. Awareness can lead to an early diagnosis and prompt treatment, which may provide relief and a longer survival time. Therefore, patients at high risck for lymphomatous infiltration should be considered for early prophylatic treatment. However, this point awaits further definition.
